updat model follow recent result saw
organ growth ep expect along upwardli revis guidanc
ep forecast unchang ep tick
slightli lower interest rate assumpt ge-rel debt financ
pt move maintain buy
publish updat model updat model post recent report
maintain ep forecast rais ep
pt move light recent strength evid across
bioprocess ecosystem pll sartoriu report except
result continu see scope upsid accret expect
ge biopharma deal step back continu view rel
safehaven increasingli choppi tool landscap believ premium valuat
warrant given structur improv growth profil post-g defens recur
mix limit cyclic industri exposur mix scope pot upsid
ge deal synergi long margin expans runway strong dbs-led execut
pleas see analyst certif import disclosur inform inform regard statu non-u analyst
page report
price target impli ep
acceler synergi captur recent
price target impli ep
price target impli ep
dhr dramat portfolio evolut escal
secular organ revenu growth profil
reduc enterpris oper volatil
consider exposur favor secular growth
dynam way life scienc diagnost
dental market key invest merit view
see premium peer justifi structur
scrope potenti upsid ge deal synergi
close acquisit
spin dental divis
pleas see import disclosur inform page report
pleas see import disclosur inform page report
danah corporationhistor project statement incomedollar million except per share amount fiscal year end decemb histor net product incom incom share share analysisgross research sg ebitda oper margin incom net omx y/i growth analysisnet gross research sg oper incom net dilut danah corpor jefferi llc equiti research
diversifi global scienc technolog portfolio compani lead brand oper health care life scienc
research diagnost dental biopharmaceut manufactur environment water qualiti industri product id industri
complet spin-off legaci industri busi test measur retail/commerci petroleum industri
new independ compani juli
pt repres horizon dcf impli nopat compound-annual-growth-rate ep risk macro care util
reimburs asp pressur diagnost misstep china/tariff
brandon couillard certifi view express research report accur reflect person view subject
secur subject compani also certifi part compens directli indirectli relat
specif recommend view express research report
matthew stanton certifi view express research report accur reflect person view subject
secur subject compani also certifi part compens directli indirectli relat
specif recommend view express research report
case jefferi employe analyst respons coverag financi instrument discuss
report receiv compens base part overal perform firm includ invest bank incom seek
updat research appropri variou regul may prevent us asid certain industri report publish
period basi larg major report publish irregular interv appropri analyst judgement
articl articl
explan jefferi rate
buy describ secur expect provid total return price appreci plu yield within period
hold describ secur expect provid total return price appreci plu yield plu minu within
under-perform describ secur expect provid total return price appreci plu yield minu less within
expect total return price appreci plu yield buy rate secur averag secur price consist
within period compani typic volatil overal stock market hold rate
secur averag secur price consist expect total return price appreci plu yield plu minu
within period under-perform rate secur averag secur price consist expect
total return price appreci plu yield minu less within period
nr invest rate price target temporarili suspend suspens complianc applic
cs coverag suspend jefferi suspend coverag compani
nc cover jefferi cover compani
restrict describ issuer conjunct jefferi engag certain transact compani polici applic
secur regul prohibit certain type commun includ invest recommend
monitor describ secur whose compani fundament financi monitor financi project
opinion invest merit compani provid
pleas see import disclosur inform page report
